Blanket Purchase Agreement FA239625AB003
Award Date
12/1/24
Last Date to Order
11/30/29
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Air Force
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation to provide reagents, kits, and consumables for immunochemistry and clinical chemistry testing. The 5-year, $37 million BPA will enable DHA, which includes the U.S. Air Force School of Aerospace Medicine (USAFSAM), to acquire these critical laboratory supplies as needed to support healthcare services for veterans, active duty military personnel, dependents, retirees, and...
The Blanket Purchase Agreement (BPA) contract FA301625A0005 was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The single-award, $4,500,000 BPA was issued by the Air Education and Training Command, a Defense agency, with a period of performance from October 1, 2024 to May 1, 2027. The BPA is intended to provide the agency with streamlined access to a variety of Roche's...
The Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, valued at $3,180,000.00, was awarded by the Defense Health Agency, a defense agency, to provide a variety of medical laboratory products and services over a period of 5 years with a completion date of October 16, 2027. The BPA allows the agency to acquire chemistry and immunochemistry laboratory testing, including critical care analyzers, reagents, test kits, and associated equipment, supplies, and services on an...
This series of Blanket Purchase Agreement (BPA) awards to Roche Diagnostics Corporation provide the U.S. Department of Defense's Defense Health Agency (DHA) and Air Force Life Cycle Management Center (AFLCMC) with critical medical equipment, reagents, and consumables to support laboratory operations at military treatment facilities and the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The BPA awards, issued against Roche's existing General Services Administration...
Roche Diagnostics Corporation has been awarded a blanket purchase agreement (BPA) by the Defense Health Agency to provide various medical diagnostic products and services. The BPA utilizes firm fixed price calls issued against it to procure items such as COBAS assays, laboratory equipment and supplies, and cardiopulmonary resuscitation testing. These products and services support the Agency's global network of medical facilities and aid in diagnostic testing, medical research, and healthcare...
Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024. A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,473,733.46, is a call under Roche's General Services Administration (GSA) Schedule 66-III for Critical Analyzers, Laboratory, and has a period of performance ending on September 30, 2024. The BPA call requires Roche...
The Department of the Army Medical Command awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation on July 22, 2022. The potential value of the BPA is $625,000 for the procurement of reagents and supplies with an ordering period through July 21, 2023. Roche Diagnostics Corporation will provide reagents and supplies to support the Department of the Army Medical Command's medical operations under the BPA. As the prime contractor, Roche will supply products to various...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The BPA and associated task orders provide the USAFSAM Epidemiology Laboratory with Roche's COVID-19 testing equipment, including automated molecular testing platforms, as well as associated kits, reagents, and...
The Defense Health Agency awarded a blanket purchase agreement to Roche Diagnostics Corporation with a potential value of $20 million. The BPA will facilitate orders for COVID-19 test kits and medical supplies to support the Agency's testing, research, and healthcare programs. Task orders issued against the BPA indicate Roche will provide reagents, test kits, consumables, diagnostic equipment, and laboratory supplies from its facilities in Bethesda, Maryland and Castleton, Indiana. Orders...